Joint Filing AgreementJoint Filing Agreement • August 7th, 2023 • Bigger Capital Fund L P • Services-computer programming, data processing, etc.
The undersigned hereby agree that the Statement on Schedule 13G dated August 7, 2023 with respect to the shares of Tego Cyber Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • September 12th, 2022 • Bigger Capital Fund L P • Dental equipment & supplies
The undersigned hereby agree that the Statement on Schedule 13G dated September 12, 2022 with respect to the shares of Common Stock of Bruush Oral Care Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • October 11th, 2022 • Bigger Capital Fund L P • Services-computer programming services
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of the Schedule 13D (including any amendments thereto) with respect to the shares of Common Stock, par value $0.00001, of Sysorex, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Joint Filing AgreementJoint Filing Agreement • May 1st, 2020 • Bigger Capital Fund L P • Semiconductors & related devices
The undersigned hereby agree that the Statement on Schedule 13G dated April 21, 2020 with respect to the shares of Common Stock of Summit Wireless Technologies, Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • July 14th, 2022 • Bigger Capital Fund L P • Services-business services, nec
The undersigned hereby agree that the Statement on Schedule 13G dated July 14, 2022 with respect to the shares of Common Stock of Auto Parts 4Less Group, Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • January 2nd, 2018 • Bigger Capital Fund L P • In vitro & in vivo diagnostic substances
The undersigned hereby agree that the Statement on Schedule 13G dated January 2, 2018 with respect to the shares of Common Stock of Akers Biosciences, Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • September 4th, 2018 • Bigger Capital Fund L P • Biological products, (no disgnostic substances)
The undersigned hereby agree that the Statement on Schedule 13G dated September 4, 2018 with respect to the shares of Common Stock of Trovagene, Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • November 30th, 2020 • Bigger Capital Fund L P • Pharmaceutical preparations
The undersigned hereby agree that the Statement on Schedule 13G dated November 30, 2020 with respect to the Ordinary Shares of Therapix Biosciences Ltd., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • December 13th, 2018 • Bigger Capital Fund L P • Pharmaceutical preparations
The undersigned hereby agree that the Statement on Schedule 13G dated December 13, 2018 with respect to the shares of Common Stock of Wize Pharma, Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • November 2nd, 2020 • Bigger Capital Fund L P • Surgical & medical instruments & apparatus
The undersigned hereby agree that the Statement on Schedule 13G dated November 2,2020 with respect to the shares of Common Stock of InVivo Therapeutics Holdings Corp., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • June 13th, 2022 • Bigger Capital Fund L P • Phonograph records & prerecorded audio tapes & disks
The undersigned hereby agree that the Statement on Schedule 13G dated June 10, 2022 with respect to the shares of Common Stock of The Singing Machine Company, Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • February 11th, 2022 • Bigger Capital Fund L P • Pharmaceutical preparations
The undersigned hereby agree that the Statement on Schedule 13G Amendment Number 2 dated February 11, 2022 with respect to the Ordinary Shares of SciSparc, Ltd., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • October 3rd, 2018 • Bigger Capital Fund L P • Services-equipment rental & leasing, nec
The undersigned hereby agree that the Statement on Schedule 13G dated October 3, 2018 with respect to the shares of Common Stock of FlexShopper, Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • June 18th, 2018 • Bigger Capital Fund L P • Biological products, (no disgnostic substances)
The undersigned hereby agree that the Statement on Schedule 13G dated June 18, 2018 with respect to the shares of Common Stock of Trovagene, Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • April 6th, 2023 • Bigger Capital Fund L P • Surgical & medical instruments & apparatus
The undersigned hereby agree that the Statement on Schedule 13G dated April 3, 2023 with respect to the ordinary shares of G Medical Innovations Holdings Ltd., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • November 2nd, 2018 • Bigger Capital Fund L P • Surgical & medical instruments & apparatus
The undersigned hereby agree that the Statement on Schedule 13G dated November 2, 2018 with respect to the shares of Common Stock of MEDITE Cancer Diagnostics, Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • February 1st, 2019 • Bigger Capital Fund L P • Services-help supply services
The undersigned hereby agree that the Statement on Schedule 13G dated February 1, 2019 with respect to the shares of Common Stock of Staffing 360 Solutions, Inc. and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • October 10th, 2023 • Bigger Capital Fund L P • Beverages
The undersigned hereby agree that the Statement on Schedule 13G/A No. 3 dated October 10, 2023 with respect to the shares of Common Stock of Eastside Distilling, Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • February 21st, 2023 • Bigger Capital Fund L P • Electromedical & electrotherapeutic apparatus
The undersigned hereby agree that the Statement on Schedule 13G dated February 21, 2023 with respect to the shares of Common Stock of Tivic Health Systems, Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • February 28th, 2018 • Bigger Capital Fund L P • Surgical & medical instruments & apparatus
The undersigned hereby agree that the Statement on Schedule 13G dated February 28, 2018 with respect to the shares of Common Stock of MEDITE Cancer Diagnostics, Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • November 1st, 2019 • Bigger Capital Fund L P • Electromedical & electrotherapeutic apparatus
The undersigned hereby agree that the Statement on Schedule 13G dated November 1, 2019 with respect to the shares of Common Stock of CHF Solutions, Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • November 14th, 2019 • Bigger Capital Fund L P • Electromedical & electrotherapeutic apparatus
The undersigned hereby agree that the Statement on Amendment No. 1 to Schedule 13G dated November 14, 2019 with respect to the shares of Common Stock of CHF Solutions, Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • July 9th, 2018 • Bigger Capital Fund L P • Surgical & medical instruments & apparatus
The undersigned hereby agree that the Statement on Schedule 13G dated July 9, 2018 with respect to the shares of Common Stock of Inspire MD, Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • March 8th, 2018 • Bigger Capital Fund L P • Pharmaceutical preparations
The undersigned hereby agree that the Statement on Schedule 13G dated March 8, 2018 with respect to the shares of Common Stock of Aytu BioScience, Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • July 14th, 2023 • Bigger Capital Fund L P • Surgical & medical instruments & apparatus
The undersigned hereby agree that the Statement on Schedule 13G dated July 14, 2023 with respect to the Common Stock of Arch Therapeutics, Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • October 4th, 2023 • Bigger Capital Fund L P • Surgical & medical instruments & apparatus
The undersigned hereby agree that the Statement on Schedule 13G dated October 3, 2023 with respect to the Common Stock of Intelligent Bio Solutions Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
